Hamostaseologie. 2004 May;24(2):135-43.

[Lepirudin for therapeutic use in heparin-induced thrombocytopenia].

[Article in German]

Harenberg J, Jörg I, Koch S, Fenyvesi T.

Source

IV. Medizinische Klinik, Universitätsklinikum Mannheim, Theodor-Kutzer-Ufer, 68167 Mannheim. J-Harenberg@t-online.de

Abstract

Heparin-induced thrombocytopenia (HIT) type II is an antibody mediated severe adverse event to heparin with a paradoxical decrease of platelet count and an increased risk for thromboembolic complications. The antibodies are directed against a neoepitop of platelet factor 4 after its binding to heparin. The incidence of HIT type II is lower with low-molecular-weight heparin compared to unfractionated heparin and lower in not operated patients compared to those after major surgery. In patients with HIT type II alternative anticoagulation has to be performed immediately due to the high thrombogenicity of the antibodies. The recombinant hirudin lepirudin (Refludan) is the anticoagulant drug of choice. A long-term anticoagulation has to be performed depending on the concomitant risk factors, intravenous administration followed by subcutaneous lepirudin overlapping with vitamin K antagonists.

PMID:: 15136878; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Schattauer Verlag - PDF

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Molecular Biology Databases

HEPARIN - HSDB

Supplemental Content

Save items

Related citations in PubMed

The management of heparin-induced thrombocytopenia. [Br J Haematol. 2006]
The management of heparin-induced thrombocytopenia.
Keeling D, Davidson S, Watson H, Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology. Br J Haematol. 2006 May; 133(3):259-69.
Lepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia. Heparin-Associated Thrombocytopenia Study (HAT) investigators. [Circulation. 1999]
Lepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia. Heparin-Associated Thrombocytopenia Study (HAT) investigators.
Greinacher A, Janssens U, Berg G, Böck M, Kwasny H, Kemkes-Matthes B, Eichler P, Völpel H, Pötzsch B, Luz M. Circulation. 1999 Aug 10; 100(6):587-93.
Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study. [Circulation. 1999]
Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study.
Greinacher A, Völpel H, Janssens U, Hach-Wunderle V, Kemkes-Matthes B, Eichler P, Mueller-Velten HG, Pötzsch B. Circulation. 1999 Jan 5-12; 99(1):73-80.
Review The use of direct thrombin inhibitors in cardiovascular surgery in patients with heparin-induced thrombocytopenia. [Semin Thromb Hemost. 2004]
Review The use of direct thrombin inhibitors in cardiovascular surgery in patients with heparin-induced thrombocytopenia.
Greinacher A. Semin Thromb Hemost. 2004 Jun; 30(3):315-27.
Review Heparin-induced thrombocytopenia: when a low platelet count is a mandate for anticoagulation. [Hematology Am Soc Hematol Educ...]
Review Heparin-induced thrombocytopenia: when a low platelet count is a mandate for anticoagulation.
Ortel TL. Hematology Am Soc Hematol Educ Program. 2009; :225-32.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

[Lepirudin for therapeutic use in heparin-induced thrombocytopenia].
[Lepirudin for therapeutic use in heparin-induced thrombocytopenia].
Hamostaseologie. 2004 May ;24(2):135-43.

PubMed
A theory of the mind/brain dichotomy with special reference to the contribution ...
A theory of the mind/brain dichotomy with special reference to the contribution of positron emission tomography.
Perspect Biol Med. 1992 Summer ;35(4):549-71.

PubMed
Emerging experimental therapeutics for bipolar disorder: insights from the molec...
Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers.
Mol Psychiatry. 2004 Aug ;9(8):734-55.

PubMed
Similar gene expression patterns characterize aging and oxidative stress in Dros...
Similar gene expression patterns characterize aging and oxidative stress in Drosophila melanogaster.
Proc Natl Acad Sci U S A. 2004 May 18 ;101(20):7663-8. Epub 2004 May 10 .

PubMed
Distal myopathy with rimmed vacuoles (DMRV): new GNE mutations and splice varian...
Distal myopathy with rimmed vacuoles (DMRV): new GNE mutations and splice variant.
Neurology. 2004 May 11 ;62(9):1607-10.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: